Home › Parkinson's Disease › Colorado
Parkinson's Disease clinical trials in Colorado
15 studies for Parkinson's Disease are looking for participants at sites in Colorado.
Cities in Colorado
Neocortical Microarchitecture of Executive Function
- University of Colorado, Aurora
Recruiting
Ages 45 to 85 · All sexes · Updated Nov 13, 2026 · NCT06778135SAD Study in Patients With Parkinson's Disease and Motor Fluctuations
- Rocky Mountain Clinical Research, Englewood
RecruitingPhase 1
Ages 40 to 80 · All sexes · Updated Nov 12, 2026 · NCT07422675Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
- University of Colorado, Aurora
- St. Mary's Hospital and Medical Center, Grand Junction
RecruitingObservational study
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT02071134A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
- Rocky Mountain Movement Disorders, Englewood
RecruitingPhase 3
Ages 50 to 85 · All sexes · Updated Nov 5, 2026 · NCT07174310A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
- University of Colorado Hospital - Neurology Clinic, Aurora
RecruitingPhase 3
Ages 45 to 75 · All sexes · Updated Nov 2, 2026 · NCT06944522Investigating Basal Ganglia-Cortical Physiology During Sleep and Its Modulation by Adaptive Deep Brain Stimulation in Parkinson Disease
- University of Colorado, Aurora
Recruiting
Ages 45 to 75 · All sexes · Updated Oct 30, 2026 · NCT07808346A Study of Buntanetap in Participants With PD
- Cenexel Rocky Mountain Clinical Research, Englewood
RecruitingPhase 2/3
Ages 40 to 85 · All sexes · Updated Oct 30, 2026 · NCT07284784A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
- University of Colorado - Anschutz Medical Campus, Aurora
RecruitingPhase 2
Ages 40 to 80 · All sexes · Updated Oct 30, 2026 · NCT06680830A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
- Rocky Mountain Clinical Research - CenExel - PPDS (Site #215), Englewood
RecruitingPhase 2
Ages 30 to 80 · All sexes · Updated Oct 28, 2026 · NCT07432958A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
- Site-025, Aurora
RecruitingPhase 2/3
Ages 40 to 80 · All sexes · Updated Oct 22, 2026 · NCT06976268A Clinical Trial of LY3962681 in Healthy Volunteers and in Patients With Parkinson's Disease
- CenExel, Englewood
RecruitingPhase 1Healthy volunteers welcome
Ages 30 to 80 · All sexes · Updated Oct 16, 2026 · NCT06565195Parkinson's Foundation PD GENEration Genetic Registry
- University of Colorado Anschutz, Aurora
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT04994015PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
- University of Colorado Anschutz Medical Campus, Aurora
RecruitingObservational studyHealthy volunteers welcome
Ages 30 and older · All sexes · Updated Jul 27, 2026 · NCT04477785Use of CereGate Therapy for Freezing of Gait in PD
- University of Colorado Anschutz Medical Campus, Aurora
Recruiting
Ages 21 to 80 · All sexes · Updated May 28, 2026 · NCT05292794Study to Investigate Vagus Nerve Stimulation to Augment Executive Function in Healthy and Cognitively Impaired Populations
- Clinical Translational Research Center at CU Anschutz, Aurora
RecruitingHealthy volunteers welcome
Ages 18 to 65 · All sexes · Updated Feb 20, 2026 · NCT07424365From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.